Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's letter to the editor re: Konrad H. Stopsack. Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024 Correspondence


Author: Stopsack, K. H.
Title: Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's letter to the editor re: Konrad H. Stopsack. Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
Journal Title: European Urology
Volume: 79
Issue: 3
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2021-03-01
Start Page: e81
End Page: e82
Language: English
DOI: 10.1016/j.eururo.2020.12.018
PUBMED: 33358233
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Export Date: 1 March 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors